These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 15782142

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Significance of skp2 expression in primary breast cancer.
    Sonoda H, Inoue H, Ogawa K, Utsunomiya T, Masuda TA, Mori M.
    Clin Cancer Res; 2006 Feb 15; 12(4):1215-20. PubMed ID: 16489076
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A, Yoshino I, Tanaka S, Sugio K, Kameyama T, Yamaguchi M, Maehara Y.
    J Clin Oncol; 2004 Oct 15; 22(20):4165-73. PubMed ID: 15483027
    [Abstract] [Full Text] [Related]

  • 5. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.
    Kudo Y, Kitajima S, Sato S, Miyauchi M, Ogawa I, Takata T.
    Cancer Res; 2001 Oct 01; 61(19):7044-7. PubMed ID: 11585732
    [Abstract] [Full Text] [Related]

  • 6. Skp2 is oncogenic and overexpressed in human cancers.
    Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J, Krek W.
    Proc Natl Acad Sci U S A; 2001 Apr 24; 98(9):5043-8. PubMed ID: 11309491
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.
    Chiappetta G, De Marco C, Quintiero A, Califano D, Gherardi S, Malanga D, Scrima M, Montero-Conde C, Cito L, Monaco M, Motti ML, Pasquinelli R, Agosti V, Robledo M, Fusco A, Viglietto G.
    Endocr Relat Cancer; 2007 Jun 24; 14(2):405-20. PubMed ID: 17639054
    [Abstract] [Full Text] [Related]

  • 8. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
    Uddin S, Ahmed M, Bavi P, El-Sayed R, Al-Sanea N, AbdulJabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Hussain AR, Al-Kuraya KS.
    Cancer Res; 2008 May 01; 68(9):3379-88. PubMed ID: 18451165
    [Abstract] [Full Text] [Related]

  • 9. The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E.
    Yeh KH, Kondo T, Zheng J, Tsvetkov LM, Blair J, Zhang H.
    Biochem Biophys Res Commun; 2001 Mar 09; 281(4):884-90. PubMed ID: 11237742
    [Abstract] [Full Text] [Related]

  • 10. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.
    Shim EH, Johnson L, Noh HL, Kim YJ, Sun H, Zeiss C, Zhang H.
    Cancer Res; 2003 Apr 01; 63(7):1583-8. PubMed ID: 12670908
    [Abstract] [Full Text] [Related]

  • 11. Basic investigation on the development of molecular targeting therapy against cyclin-dependent kinase inhibitor p27Kip1 in head and neck cancer cells.
    Supriatno, Harada K, Yoshida H, Sato M.
    Int J Oncol; 2005 Sep 01; 27(3):627-35. PubMed ID: 16077910
    [Abstract] [Full Text] [Related]

  • 12. Inverse correlation between expression levels of p27 and the ubiquitin ligase subunit Skp2 in early esophageal squamous cell carcinoma.
    Fukuchi M, Masuda N, Nakajima M, Fukai Y, Miyazaki T, Kato H, Kuwano H.
    Anticancer Res; 2004 Sep 01; 24(2B):777-83. PubMed ID: 15161026
    [Abstract] [Full Text] [Related]

  • 13. Prognostic impact of Skp2 and p27 in human breast cancer.
    Traub F, Mengel M, Lück HJ, Kreipe HH, von Wasielewski R.
    Breast Cancer Res Treat; 2006 Sep 01; 99(2):185-91. PubMed ID: 16636894
    [Abstract] [Full Text] [Related]

  • 14. Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship.
    Li Q, Murphy M, Ross J, Sheehan C, Carlson JA.
    J Cutan Pathol; 2004 Nov 01; 31(10):633-42. PubMed ID: 15491322
    [Abstract] [Full Text] [Related]

  • 15. Skp2 inversely correlates with p27 and tuberin in transformed cells.
    Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschläger M.
    Amino Acids; 2009 Jul 01; 37(2):257-62. PubMed ID: 18604603
    [Abstract] [Full Text] [Related]

  • 16. Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms.
    Chen TP, Chen CM, Chang HW, Wang JS, Chang WC, Hsu SI, Cho CL.
    Gynecol Oncol; 2007 Mar 01; 104(3):516-23. PubMed ID: 17079005
    [Abstract] [Full Text] [Related]

  • 17. The F box protein S phase kinase-associated protein 2 regulates adipose mass and adipocyte number in vivo.
    Cooke PS, Holsberger DR, Cimafranca MA, Meling DD, Beals CM, Nakayama K, Nakayama KI, Kiyokawa H.
    Obesity (Silver Spring); 2007 Jun 01; 15(6):1400-8. PubMed ID: 17557977
    [Abstract] [Full Text] [Related]

  • 18. A novel route for connexin 43 to inhibit cell proliferation: negative regulation of S-phase kinase-associated protein (Skp 2).
    Zhang YW, Nakayama K, Nakayama K, Morita I.
    Cancer Res; 2003 Apr 01; 63(7):1623-30. PubMed ID: 12670914
    [Abstract] [Full Text] [Related]

  • 19. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
    Schepers H, Wierenga AT, Eggen BJ, Vellenga E.
    Exp Hematol; 2005 Jul 01; 33(7):747-57. PubMed ID: 15963850
    [Abstract] [Full Text] [Related]

  • 20. COX-2 correlates with F-box protein, Skp2 expression and prognosis in human gastric carcinoma.
    Honjo S, Kase S, Osaki M, Ardyanto TD, Kaibara N, Ito H.
    Int J Oncol; 2005 Feb 01; 26(2):353-60. PubMed ID: 15645119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.